alteogen novartis sandoz alt-b4

Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...

South Korea's Alteogen Inc., Enchem Co., and HD Hyundai Electric Co. will be added to the Morgan Stanley Capital International (MSCI) Korea Index.MS...

HD Hyundai Electric Co., Alteogen Inc. and Enchem Co. are expected to be invited to join Morgan Stanley Capital International’s Korea Index wh...

Chong Kun Dang Pharmaceutical Corp.'s shares zoomed more than 25% on Monday on news that the South Korean medicine developer has signed its biggest-...

Samsung Bioepis Co., a biopharmaceutical research and development unit under South Korea's Samsung Group, announced on Monday that it signed a partn...

Samsung Biologics Co., the world’s top contract manufacturing organization by capacity, inked a $391 million contract from Novartis, nearly fi...

Alt-A, which provides a transportation system specialized in last-mile roads, said Monday that it has received pre-series A funding from Shinh...

South Korea's bio company Alteogen Inc. on Friday said it signed its fourth technology export contract since its 2018 development of the human recom...

South Korea’s Samsung Biologics Co. has inked an $81 million contract manufacturing deal with Novartis, the world’s fifth-largest pharma...

South Korea’s retail conglomerate Shinsegae Group’s food affiliate Shinsegae Food Inc. has entered the fast-growing alternative meat mar...

Korea Investment & Securities Co. Ltd. is set to buy an office building of Swiss pharmaceutical company Novartis under construction in Paris for 5...